Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Treatment of anal carcinoma in immune-compromised patients
Clinical and Translational Oncology, 10/07/09
Barriger RB et al. – Most HIV–positive and organ transplant patients receiving radiotherapy with or without chemotherapy experience acute toxicity but few have chronic complications. T–stage and CD4 level in HIV–positive patients predict for LC. T–stage and TT predict for OS.
Related Articles
Current therapeutic strategies for anal squamous cell carcinoma in Japan
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 67%
Human papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies
Modern Pathology, 10/23/09
Relevance Score: 67%
Squamous cell cancer of the rectum
World Journal of Gastroenterology, 10/01/09
Relevance Score: 65%
Invasive papillary carcinoma of the male breast: Report of a rare case and review of the literature
Journal of Cancer Research and Therapeutics, 10/28/09
Relevance Score: 46%
Anal cytology in patients with AIDS
Diagnostic Cytopathology, 10/14/09
Relevance Score: 46%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Barriers to Integrating Gene Profiling for Stage II Colon Cancer
Clinical Cancer Research, 12/11/09
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
Clinical Cancer Research, 12/11/09
Radiation Therapy for Rectal Cancer: Current Status and Future Directions
Cancer Control, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


